ALPA LABORATORIES
Back to Balance Sheet
|
ALPA LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4.49 Cr | ₹2.40 Cr | ₹3.06 Cr | ₹4.70 Cr | ₹0.23 Cr |
What is the latest Total Non-Current Liabilities ratio of ALPA LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹4.49 Cr |
| Mar2024 | ₹2.40 Cr |
| Mar2023 | ₹3.06 Cr |
| Mar2022 | ₹4.70 Cr |
| Mar2021 | ₹0.23 Cr |
How is Total Non-Current Liabilities of ALPA LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.49 Cr | 87.52 | |
| Mar2024 | ₹2.40 Cr | -21.70 | |
| Mar2023 | ₹3.06 Cr | -34.82 | |
| Mar2022 | ₹4.70 Cr | 1,986.67 | |
| Mar2021 | ₹0.23 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALPA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALPA LABORATORIES | ₹128.7 Cr | -0.8% | -6% | -37% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
ALPA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALPA LABORATORIES | -0.8% |
-6% |
-37% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses